The observation that MMF and CX-5461 reduce LEDGF and menin protein, leading to reduced chromatin occupancy of the menin/MLL-fusion complex raised the possibility that MMF and CX-5461 may sensitize AML cells to menin inhibitors. Here, KMT2A is linked to acute myeloid leukemia.